SALARIUS PHARMACEUTICALS INC's ticker is SLRX and the CUSIP is 79400X107. A total of 29 filers reported holding SALARIUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $23,000 | -62.3% | 115,683 | -60.4% | 0.00% | – |
Q2 2022 | $61,000 | +662.5% | 291,900 | +1350.2% | 0.00% | – |
Q1 2022 | $8,000 | -75.0% | 20,128 | -69.3% | 0.00% | – |
Q4 2021 | $32,000 | -47.5% | 65,577 | +10.3% | 0.00% | – |
Q3 2021 | $61,000 | +74.3% | 59,480 | +77.6% | 0.00% | – |
Q2 2021 | $35,000 | -16.7% | 33,488 | +16.8% | 0.00% | – |
Q1 2021 | $42,000 | +121.1% | 28,675 | +40.5% | 0.00% | – |
Q4 2020 | $19,000 | -17.4% | 20,402 | -24.9% | 0.00% | – |
Q3 2020 | $23,000 | – | 27,163 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
X-Square Capital, LLC | 97,258 | $39,000 | 0.02% |
Kepos Capital LP | 548,054 | $218,000 | 0.02% |
Virtu Financial LLC | 39,476 | $16,000 | 0.00% |
Laird Norton Wetherby Wealth Management, LLC | 39,746 | $16,000 | 0.00% |
SHUFRO ROSE & CO LLC | 16,400 | $7,000 | 0.00% |
NORTHERN TRUST CORP | 65,022 | $26,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 390,115 | $155,000 | 0.00% |
STATE STREET CORP | 142,552 | $57,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 20,128 | $8,000 | 0.00% |